Acknowledgments
The Canadian Scleroderma Research Group (CSRG) is funded by Scleroderma Canada, The Scleroderma Society of Ontario, and many pharmaceutical companies. We thank the following pharmaceutical partners for website support and educational grants Boehringer Ingelheim, Janssen, Mallinckrodt and Fresenius Kabi.
We value our past partnerships with Canadian Institute of Health Research (CIHR) as well as the Scleroderma Association of Saskatchewan, Scleroderma Manitoba, the Scleroderma Society of Nova Scotia, the Scleroderma Association of British Colombia, the Cure Scleroderma Foundation, The Canadian Blood and Marrow Transplant Group, and the Lady Davis Institute of Medical Research of the Jewish General Hospital.
Investigators of the Canadian Scleroderma Research Group
M. Baron, Montreal, Quebec; M. Hudson, Montreal, Quebec; G. Gyger, Montreal, Quebec; S. Hoa, Montreal, Quebec; J. Pope, London, Ontario; M. Larché, Hamilton, Ontario; N. Khalidi, Hamilton, Ontario; A. Masetto, Sherbrooke, Quebec; E. Sutton, Halifax, Nova Scotia; T.S. Rodriguez-Reyna, Mexico City, Mexico; N. Maltez, Ottawa, Ontario; C. Thorne, Newmarket, Ontario; P.R. Fortin, Quebec, Quebec; A. Ikic, Quebec, Quebec, D. Robinson, Winnipeg, Manitoba; N. Jones, Edmonton, Alberta; S. LeClercq, Calgary, Alberta; J-P. Mathieu, Montreal, Quebec; P. Docherty, Moncton, New Brunswick; D. Smith, Ottawa, Ontario; M. Fritzler, Mitogen Advanced Diagnostics Laboratory, Calgary, Alberta.